Zepp Health Co. (NYSE:ZEPP - Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 8,400 shares, an increase of 211.1% from the February 28th total of 2,700 shares. Based on an average daily trading volume, of 19,800 shares, the days-to-cover ratio is currently 0.4 days. Approximately 0.1% of the shares of the company are short sold.
Institutional Trading of Zepp Health
A hedge fund recently bought a new stake in Zepp Health stock. Virtu Financial LLC bought a new stake in shares of Zepp Health Co. (NYSE:ZEPP - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 13,056 shares of the company's stock, valued at approximately $57,000. Virtu Financial LLC owned 0.09% of Zepp Health at the end of the most recent reporting period. Hedge funds and other institutional investors own 52.61% of the company's stock.
Zepp Health Stock Performance
Shares of ZEPP stock traded down $0.04 on Monday, hitting $2.96. 25,843 shares of the stock were exchanged, compared to its average volume of 19,583. The firm's 50 day moving average is $2.98 and its two-hundred day moving average is $3.10. Zepp Health has a one year low of $2.06 and a one year high of $4.38. The firm has a market capitalization of $44.55 million, a PE ratio of -1.18 and a beta of 0.75. The company has a current ratio of 1.21, a quick ratio of 0.87 and a debt-to-equity ratio of 0.13.
Zepp Health Company Profile
(
Get Free Report)
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.
Featured Articles
Before you consider Zepp Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.
While Zepp Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.